July 2024

TibaRay CEO, Jeff Amacker and Leo Cancer Care CEO, Stephen Trowe talk about collaboration at PTCOG in Singapore:
Bill Loo, TibaRay Founder & Board Member, talks Upright Radiotherapy at PTCOG in Singapore:

June 2024

Leo Cancer Care and TibaRay Collaborate to Co-Develop Next-Generation Upright Linear Accelerator

A unique partnership agreement signed between upright radiotherapy specialists Leo Cancer Care and innovative linear accelerator manufacturers TibaRay will see the development of a first-of-its-kind upright linear accelerator. Read More...

March 2023

TibaRay Secures New Corporate Headquarters with Integrated Radiation Vault

TibaRay recently signed a multi-year lease agreement to secure a 24,000 square foot facility in Fremont, CA to serve as the Company’s future headquarters. The Fremont facility is well-suited to TibaRay’s long-term strategic plan, as it includes a pre-existing radiation vault ideal for future development of the Company’s novel PHASER radiotherapy system and its components. The Company will transition from its existing facility in Santa Clara, CA to the Fremont facility in the coming months of 2023. Read More...

February 2023

TibaRay Awarded $400K Contract from the National Cancer Institute for Ultra-Rapid FLASH Beam Monitoring and Control Technology Development

The National Cancer Institute recently awarded TibaRay a $400K contract to develop a highly sensitive and ultra-fast radiation therapy (RT) FLASH dosimetry monitoring and control system. Conventional dose monitoring devices demonstrate non-linear behavior when used for FLASH RT applications, demanding the development of novel state-of-the-art hardware capable of measuring and controlling FLASH dose rates that are two to three orders of magnitude higher than conventional RT doses. Inclusive of this contract, TibaRay has now received funding of more than $10M from the Department of Energy and the National Institute of Health. Read More...

January 2023

FLASH Research Garners World-Wide Interest and Reinforces TibaRay’s Strategy

The second annual FLASH Radiotherapy and Particle Therapy (FRPT) Conference was held in Barcelona, Spain in December 2022. More than 600 global participants attended the conference, whose objective was to promote the rigorous scientific study of FLASH therapy. Diverse presentation topics included studies exploring the fundamental biological mechanisms of FLASH therapy, technological developments, veterinary studies, and clinical trials. A common theme throughout the conference was the replication of the “FLASH effect" across multiple experimental models from independent researchers. Read More...

October 2022

TibaRay Receives First Place Award from Global Forum at the 5th Annual Global Innovation Start-Up Competition

TibaRay proudly received the gold award – the highest honor possible – at the 5th Annual Global Innovation Start-Up Competition sponsored by Global Forum. Global Forum is an international, high-level, not-for-profit think-tank dedicated to the main technological, economic, social, societal, political, and ethical issues and challenges that affect the evolution of our digital society. Vinod Bharadwaj, Executive Vice President of TibaRay, represented the Company at the competition held in Muscat, Oman in October 2022. Read More...